Klinikum der Universität Würzburg

Würzburg 97080

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Solid Tumor

Studies at this site

• Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors — Completed